Decreased levels of circulating α2-Heremans-Schmid glycoprotein/Fetuin-A (AHSG) in patients with rheumatoid arthritis

Internal Medicine

Volumn 46, Issue 20, 2007, Pages 1685-1692

  Sato, Hiroe ^a   Kazama, Junichiro James ^a   Wada, Yoko ^a   Kuroda, Takeshi ^a   Narita, Ichiei ^a   Gejyo, Fumitake ^a   Gao, Ping ^a   Yamashita, Hiroyuki ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

2 Heremans Schmid glycoprotein Fetuin A (AHSG); Reumatoid arthritis; Vascular calcification

Indexed keywords

ALBUMIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CHOLESTEROL; FETUIN; GLUCOCORTICOID; GLYCOPROTEIN; HEMOGLOBIN; HYPOCHOLESTEROLEMIC AGENT; INSULIN; ACUTE PHASE PROTEIN; ALPHA2HS GLYCOPROTEIN; CALCIUM; PLASMA PROTEIN; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DRUG MEGADOSE; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPERTENSION; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; OSTEOLYSIS; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; VOLUNTEER; AORTA DISEASE; BLOOD; CALCINOSIS; MIDDLE AGED;

ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; AORTIC DISEASES; ARTHRITIS, RHEUMATOID; BLOOD PROTEINS; C-REACTIVE PROTEIN; CALCINOSIS; CALCIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOCORTICOIDS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; SERUM ALBUMIN;

EID: 35748983579     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6269     Document Type: Article

References (30)

1. Gejyo F, Schmid K. Purification and characterization of the two forms of human plasma alpha 2HS-glycoprotein. Biochim Biophys Acta 671: 78-84, 1981.
2. Gejyo F, Chang JL, Burgi W, et al. Characterization of the B-chain of human plasma alpha 2HS-glycoprotein. The complete amino acid sequence and primary structure of its heteroglycan. J Biol Chem 258: 4966-4971, 1983.
3. Gangneux C, Daveau M, Hiron M, Derambure C, Papaconstantinou J, Salier JP. The inflammation-induced down-regulation of plasma Fetuin-A (alpha2HS-glycoprotein) in liver results from the loss of interaction between long C/EBP isoforms at two neighbouring binding sites. Nucleic Acids Res 31: 5957-5970, 2003.
4. Ruminy P, Gangneux C, Claeyssens S, Scotte M, Daveau M, Salier JP. Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes. Inflamm Res 50: 383-390, 2001.
5. Swallow CJ, Partridge EA, Macmillan JC, et al. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression. Cancer Res 64: 6402-6409, 2004.
6. Kalabay L, Jakab L, Prohaszka Z, et al. Human fetuin/ alpha2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer. Eur J Gastroenterol Hepatol 14: 389-394, 2002.
7. Kishore BK, Gejyo F, Arakawa M. Alpha 2HS-glycoprotein in the serum and urine of patients with renal diseases. Postgrad Med J 59: 304-307, 1983.
8. Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetain-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357-366, 2003.
9. Kumeda Y, Inaba M, Goto H, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 46: 1489-1497, 2002.
10. Wada Y, Kuroda T, Murasawa A, Tanabe N, Nakano M, Geiyo F. Autoantibodies against oxidized low-density lipoprotein (LDL) and carotid atherosclerosis in patients with rheumatoid arthritis. Clin Exp Rheumatol 23: 482-486, 2005.
11. Wong M, Toh L, Wilson A, et al. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum 48: 81-89, 2003.
12. del Rincon, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44: 2737-2745, 2001.
13. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52: 722-732, 2005.
14. del Rincon I, Williams K, Stern MP, Freeman GL, O'Leary DH, Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 48: 1833-1840, 2003.
15. Nagata-Sakurai M, Inaba M, Goto H, et al. Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum 48: 3061-3067, 2003.
16. Arnett FC, Edworthy SM, Bloch AD, McShane DJ, Fries JF, Cooper NS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324, 1988.
17. Steinbrocker O, Traeger CH, Betteman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 140: 659-662, 1949.
18. Li J, Hannah K, Galvin MA, et al. Aortic calcification on plain cliest radiography increases risk for coronary artery disease. Chest 121: 1468-1471, 2002.
19. Iribarren C, Sidney S, Sternfeld B, Browner WS. Calcification of the aortic arch: risk factors and apociation with coronary heart disease, stroke, and peripheral vascular disease. JAMA 283: 2810-2815, 2000.
20. Dessein PH, Joffe BI. Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum 54: 27765-2775, 2006.
21. Hansson GK. Inflammation, atherosclerosis; and coronary artery disease. N Engl J Med 352: 1685-1693, 2005.
22. Kazama JJ, Gejyo F, Ei I. The, immunohistochemical localization of alpha2-Heremans-Schmid glycoprotein/fetuin-A (AHSG). Nephrol Dial Transplant 20: 851-852, 2005..
23. Price PA, Lim JE. J Biol Chem The inhibition of calcium phosphate precipitation by fetuin is accompanied liy the formation of a fetuin-mineral complex. 278: 22144-22152, 2003.
24. Schinke T, Amendt C, Trindl À, Poschke O, Muller-Esterl W, Jahnen-Dechent W. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formition in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 271: 20789-20796, 1996.
25. Merx MW, Schafer C,, Westenfeld, R, et al. Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice. J Am Soc Nephrol 16: 3357-3364, 2005.
26. Reynolds JL, Skepper. JN, McNair R, et al. Multifunctional roles. for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 16: 2920-2930, 2005.
27. Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum, with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361: 827-833, 2003.
28. Stenvinkel P, Wang K, Qureshi AR, et al. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int. 67: 2383-2392, 2005.
29. Kazama JJ, Amizuka N, Fukagawa M. Ectopic calcification as abnormal biomoneralization. The Apher Dial 10: S34-38, 2006.
30. del Rincon I, O'Leary DH, Haas RW, Escalante A. Arthritis Rheum. Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum 50: 3813-3822, 2004.